IT1312569B1 - Uso dell'enzima gssg reduttasi per il trattamento terapeutico e laprofilassi di pazienti infettati da hiv. - Google Patents

Uso dell'enzima gssg reduttasi per il trattamento terapeutico e laprofilassi di pazienti infettati da hiv.

Info

Publication number
IT1312569B1
IT1312569B1 IT1999MI001122A ITMI991122A IT1312569B1 IT 1312569 B1 IT1312569 B1 IT 1312569B1 IT 1999MI001122 A IT1999MI001122 A IT 1999MI001122A IT MI991122 A ITMI991122 A IT MI991122A IT 1312569 B1 IT1312569 B1 IT 1312569B1
Authority
IT
Italy
Prior art keywords
hiv
gssg
laprophylaxis
reducted
enzyme
Prior art date
Application number
IT1999MI001122A
Other languages
English (en)
Inventor
Raffaele Ansovini
Original Assignee
Raffaele Ansovini
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IT1999MI001122A priority Critical patent/IT1312569B1/it
Application filed by Raffaele Ansovini filed Critical Raffaele Ansovini
Priority to PT00920596T priority patent/PT1178819E/pt
Priority to DE60006519T priority patent/DE60006519T2/de
Priority to PCT/EP2000/002703 priority patent/WO2000071146A2/en
Priority to JP2000619448A priority patent/JP2003519088A/ja
Priority to AT00920596T priority patent/ATE253936T1/de
Priority to AU41116/00A priority patent/AU4111600A/en
Priority to EP00920596A priority patent/EP1178819B1/en
Priority to ES00920596T priority patent/ES2211532T3/es
Priority to DK00920596T priority patent/DK1178819T3/da
Publication of ITMI991122A1 publication Critical patent/ITMI991122A1/it
Application granted granted Critical
Publication of IT1312569B1 publication Critical patent/IT1312569B1/it
Priority to HK02105818.7A priority patent/HK1045258B/zh
Priority to US10/863,367 priority patent/US7045323B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y108/00—Oxidoreductases acting on sulfur groups as donors (1.8)
    • C12Y108/01—Oxidoreductases acting on sulfur groups as donors (1.8) with NAD+ or NADP+ as acceptor (1.8.1)
    • C12Y108/01007—Glutathione-disulfide reductase (1.8.1.7), i.e. glutathione reductase (NADPH)
IT1999MI001122A 1999-05-21 1999-05-21 Uso dell'enzima gssg reduttasi per il trattamento terapeutico e laprofilassi di pazienti infettati da hiv. IT1312569B1 (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IT1999MI001122A IT1312569B1 (it) 1999-05-21 1999-05-21 Uso dell'enzima gssg reduttasi per il trattamento terapeutico e laprofilassi di pazienti infettati da hiv.
ES00920596T ES2211532T3 (es) 1999-05-21 2000-03-28 Uso de glutation reductasa para la terapia y profilaxis de vih.
PCT/EP2000/002703 WO2000071146A2 (en) 1999-05-21 2000-03-28 Glutathione reductase for therapy and prophylaxis of aids
JP2000619448A JP2003519088A (ja) 1999-05-21 2000-03-28 Ｈｉｖ感染患者の治療および予防のためのｇｓｓｇレダクターゼの使用
AT00920596T ATE253936T1 (de) 1999-05-21 2000-03-28 Glutathion-reduktase zur behandlung und prophylaxe von aids
AU41116/00A AU4111600A (en) 1999-05-21 2000-03-28 The use of gssg reductase for the therapy and prophylaxis of hiv infected patients
PT00920596T PT1178819E (pt) 1999-05-21 2000-03-28 Glutationa-redutase para a terapia e profilaxia da sida
DE60006519T DE60006519T2 (de) 1999-05-21 2000-03-28 Glutathion-reduktase zur behandlung und prophylaxe von aids
DK00920596T DK1178819T3 (da) 1999-05-21 2000-03-28 Anvendelse af GSSG-reduktase til behandling og forebyggelse af AIDS
EP00920596A EP1178819B1 (en) 1999-05-21 2000-03-28 Glutathione reductase for therapy and prophylaxis of aids
HK02105818.7A HK1045258B (zh) 1999-05-21 2002-08-09 用於治療和預防艾滋病的谷胱甘肽還原酶
US10/863,367 US7045323B2 (en) 1999-05-21 2004-06-09 Glutathione reductase for therapy and prophylaxis of aids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI001122A IT1312569B1 (it) 1999-05-21 1999-05-21 Uso dell'enzima gssg reduttasi per il trattamento terapeutico e laprofilassi di pazienti infettati da hiv.

Publications (2)

Publication Number Publication Date
ITMI991122A1 ITMI991122A1 (it) 2000-11-21
IT1312569B1 true IT1312569B1 (it) 2002-04-22

Family

ID=11383014

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999MI001122A IT1312569B1 (it) 1999-05-21 1999-05-21 Uso dell'enzima gssg reduttasi per il trattamento terapeutico e laprofilassi di pazienti infettati da hiv.

Country Status (12)

Country Link
US (1) US7045323B2 (it)
EP (1) EP1178819B1 (it)
JP (1) JP2003519088A (it)
AT (1) ATE253936T1 (it)
AU (1) AU4111600A (it)
DE (1) DE60006519T2 (it)
DK (1) DK1178819T3 (it)
ES (1) ES2211532T3 (it)
HK (1) HK1045258B (it)
IT (1) IT1312569B1 (it)
PT (1) PT1178819E (it)
WO (1) WO2000071146A2 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1312569B1 (it) 1999-05-21 2002-04-22 Raffaele Ansovini Uso dell'enzima gssg reduttasi per il trattamento terapeutico e laprofilassi di pazienti infettati da hiv.
ITMI20010760A1 (it) * 2001-04-10 2002-10-10 Raffaele Ansovini Associazione di enzimi coadiuvante nella terapia con interferone
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
US20120244212A1 (en) * 2004-11-07 2012-09-27 Frederick Timothy Guilford Enhanced method and composition for the treatment of hiv+ tuberculosis patients with anti-retroviral drugs and liposomal encapsulation for delivery of reduced glutathione
EP2119439A3 (en) * 2005-05-17 2010-01-27 Santen Pharmaceutical Co., Ltd. Angiogenesis inhibitor for treating macular degeneration
IT1393875B1 (it) * 2009-04-29 2012-05-11 Medestea Res & Production S P A Coniugato glutatione reduttasi-peg e suo impiego come medicamento antinfluenzale
IT1401504B1 (it) 2010-08-02 2013-07-26 Cattarini Mastelli Composizione comprendente glutatione reduttasi e glutatione ossidato

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2928417A1 (de) * 1979-07-12 1981-01-29 Schering Ag Trijodierte basen
US5843641A (en) * 1993-02-26 1998-12-01 Massachusetts Institute Of Technology Methods for the daignosis, of familial amyotrophic lateral sclerosis
DE69535432T2 (de) * 1994-04-22 2007-12-06 Astellas Pharma Inc. Kolon-spezifisches Arzneistofffreisetzungssystem
AU728488B2 (en) * 1997-04-02 2001-01-11 Sankyo Company Limited Dithiolan derivatives, their preparation and their therapeutic effect
US5827886A (en) * 1997-05-07 1998-10-27 Thione International, Inc. Composition for relief of arthritis-induced symptoms
IT1312569B1 (it) 1999-05-21 2002-04-22 Raffaele Ansovini Uso dell'enzima gssg reduttasi per il trattamento terapeutico e laprofilassi di pazienti infettati da hiv.

Also Published As

Publication number Publication date
DE60006519T2 (de) 2004-06-03
EP1178819A2 (en) 2002-02-13
WO2000071146A2 (en) 2000-11-30
ITMI991122A1 (it) 2000-11-21
PT1178819E (pt) 2004-04-30
DK1178819T3 (da) 2004-02-02
WO2000071146A3 (en) 2001-03-01
ATE253936T1 (de) 2003-11-15
AU4111600A (en) 2000-12-12
HK1045258B (zh) 2004-04-02
DE60006519D1 (de) 2003-12-18
EP1178819B1 (en) 2003-11-12
US7045323B2 (en) 2006-05-16
ES2211532T3 (es) 2004-07-16
JP2003519088A (ja) 2003-06-17
HK1045258A1 (en) 2002-11-22
US20040223958A1 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
AP1697A (en) Azabicycloalkanes as CCR5 modulators.
MXPA02012712A (es) N-ureidoheterocicloalquil-piperidinas como moduladores de la actividad del receptor de quimiocinas.
TR200101859T2 (tr) Kemokin alıcı aktivitesinin modülatörleri olarak N-üreidoalkil-piperidinler
BG100455A (en) Hiv protease inhibitors
AU3126600A (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
ATE376832T1 (de) Verzögert freisetzende formulierungen von oxymorphon
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
AU2265701A (en) Anti-hiv-1 conjugates for treatment of hiv disease
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
ES2160410T3 (es) Preparados de complejos de protrombina inmunotolerantes.
BR9811298A (pt) Uso de um composto de vanádio fisiologicamente aceitável
IT1312569B1 (it) Uso dell'enzima gssg reduttasi per il trattamento terapeutico e laprofilassi di pazienti infettati da hiv.
KR100725637B1 (en) Anti-HIV-1 vaccine comprising all or part of the HIV-1 Tat protein
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.
DE60128100D1 (de) Analgetisches arzneimittel
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
WO1999051256A3 (en) Use of l-glu-l-trp in the treatment of hiv infection
RS20080141A (en) Inhibitors of the hiv integrase enzyme
EP1370697A4 (en) PEROXYREDOXIN-BASED MEDICINAL PRODUCTS FOR THE TREATMENT OF HIV-1 INFECTIONS AND METHODS OF USE
AU2002220654A1 (en) Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders
ZA200108398B (en) Anti-HIV-1 vaccine comprising all or part of the HIV-1 Tat protein.
AU2001238470A1 (en) 9-alkylamino-1-nitroacridine derivatives
AU3145400A (en) Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin
TNSN03066A1 (en) Natural antibodies active against hiv virus
AU1993601A (en) Ctage gene family